Rising Number of Clinical Trials Along with Rising R&D Investments Driving Market Growth

Home Rising Number of Clinical Trials Along with Rising R&D Investments Driving Market Growth
Written by Doug Hampton
On

DUBLIN, June 19, 2023 /PRNewswire/ — The “Clinical Trial Packaging and Labelling Market Report 2023-2033” report has been added to  ResearchAndMarkets.com’s offering.

Overall world revenue will surpass US$730 million in 2023

This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Rising Number of Clinical Trials Along with Rising R&D Investments Driving Market Growth

Pharmaceutical companies are putting a lot of emphasis on environment friendly measures across their entire value chain. The development of environmentally friendly packaging for pharmaceutical items has gained importance in recent years.

Scientists have started developing substitute materials to limit the use of plastic throughout the whole supply chain as the need to reduce plastic consumption and lower carbon footprints across industries grows. This includes clinical trial packaging supply chain as well. Hence, suppliers offering clinical trial materials with lesser environmental footprint are likely to be preferred over those who are not very environmentally friendly.

Furthermore, clinical trial packaging and labelling market holds a great potential to flourish in the future as there is a great possibilities of new clinical trials for the development of novel as key players are focusing on introducing new therapies in market.

Along with this companies are taking advantage of digital marketing in a meaningful way to spread the awareness regarding their new sustainable packaging.

Packaging Waste Likely to Challenge Market Growth

The laws regarding consistency, storage, packaging, labelling, distribution, and recall of ancillary products have been improved by the FDA and other regulatory bodies. Several economies have their own set of rules, guidelines, & regulations set by their respective regulatory bodies. This has temporarily hit the market negatively.

Also, it could lead to inventory wastage of non-compliant users/suppliers. This may hinder the market growth in the forecast period.

You need to discover how this will impact the clinical trial packaging and labelling market today, and over the next 10 years:

  • Our 239-page report provides 118 tables and 148 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial packaging and labelling prices and recent developments.

Market Dynamics

Market Driving Factors

  • Rising Number of Clinical Trials Coupled with Growing R&D Investments
  • Growing Innovations and Technological Advancements
  • Changing Regulatory Scenario

Market Restraining Factors

  • No Centralised or Uniform Drug Registration Procedure
  • Stringent Regulatory Scenario
  • High Waste

Market Opportunities

  • Tamper Proof Packaging
  • Environmentally Safe Packaging
  • Opportunities in Biologics and Biosimilars Packaging Materials

Leading companies and the potential for market growth

  • Alcami Corporation, Inc.
  • Almac Group
  • Caligor Coghlan
  • Clinigen Clinical Supplies Management
  • CordenPharma International
  • Fisher Clinical Services, Inc.
  • Korber AG
  • Mawdsley-Brooks & Co. Ltd.
  • NextPharma Technologies
  • OLIVER
  • Parexel International Corporation
  • Piramal Enterprises Ltd.
  • PCI Pharma Services
  • Sentry BioPharma Services, Inc.
  • Sharp Services, LLC
  • WestRock Company
  • WuXi AppTec
  • Xerimis

Segments Covered in the Report

Type

  • Primary Packaging
  • Secondary Packaging

End User

  • CROs
  • Drug Manufacturing Companies
  • Research Labs

Material

  • Metal
  • Plastic
  • Paper
  • Others

North America

Europe

  • Germany
  • Spain
  • UK
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC Countries
  • South Africa
  • Rest of MEA

For more information about this report visit https://www.researchandmarkets.com/r/a2w1lh

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Leave a Comment